Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IMANI CONSULTING & INVESTMENT AS
AS
Active
Org 925155586
Vangsveien 10, 1814
Askim
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2020
0 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
IMANI CONSULTING & INVESTMENT AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TH
Tom-Andre Henriksen
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JE
John Erik Selle
Board of Directors
2022
PM
Pauline Marie Rosa
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Steinar Wold
Individual
20%
20%
2023
Pauline Marie Selle
Individual
15%
15%
2023
Terje Hansen
Individual
15%
15%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on IMANI CONSULTING & INVESTMENT AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
